Literature DB >> 24661871

Nonspecific interactions of chromatin with immunoglobulin G and protein A, and their impact on purification performance.

Pete Gagnon1, Rui Nian2, Jeremy Lee2, Lihan Tan2, Sarah Maria Abdul Latiff2, Chiew Ling Lim2, Cindy Chuah2, Xuezhi Bi2, Yuansheng Yang2, Wei Zhang2, Hui Theng Gan2.   

Abstract

Chromatin released from dead host cells during in vitro production of IgG monoclonal antibodies exists mostly in complex hetero-aggregates consisting of nucleosomal arrays (DNA+histone proteins), non-histone proteins, and aberrant forms of IgG. They bind immobilized protein A more aggressively than IgG, through their nucleosomal histone components, and hinder access of IgG to Fc-specific binding sites, thereby reducing dynamic binding capacity. The majority of host cell contaminants in eluted IgG are leachates from chromatin hetero-aggregates that remain bound to protein A. Formation of turbidity in eluted IgG during pH titration is caused by neutral-pH insolubility of chromatin hetero-aggregates. NaOH is required at 500 mM to remove accumulated chromatin. A chromatin-directed clarification method removed 99% of histones, 90% of non-histone proteins, achieved a 6 log reduction of DNA, 4 log reduction of lipid-enveloped virus, and 5 log reduction of non-enveloped retrovirus, while conserving 98% of the native IgG. This suspended most of performance compromises imposed on protein A. IgG binding capacity increased ~20%. Host protein contamination was reduced about 100-fold compared to protein A loaded with harvest clarified by centrifugation and microfiltration. Aggregates were reduced to less than 0.05%. Turbidity of eluted IgG upon pH neutralization was nearly eliminated. Column cleaning was facilitated by minimizing the accumulation of chromatin.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aggregates; Capacity; Chromatin; IgG purification; Protein A; Turbidity

Mesh:

Substances:

Year:  2014        PMID: 24661871     DOI: 10.1016/j.chroma.2014.03.010

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  10 in total

1.  Development of adsorptive hybrid filters to enable two-step purification of biologics.

Authors:  Nripen Singh; Abhiram Arunkumar; Michael Peck; Alexei M Voloshin; Angela M Moreno; Zhijun Tan; Jonathan Hester; Michael C Borys; Zheng Jian Li
Journal:  MAbs       Date:  2016-12-08       Impact factor: 5.857

2.  Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells.

Authors:  Jake Chng; Tianhua Wang; Rui Nian; Ally Lau; Kong Meng Hoi; Steven C L Ho; Peter Gagnon; Xuezhi Bi; Yuansheng Yang
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 3.  The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control.

Authors:  Daniel G Bracewell; Richard Francis; C Mark Smales
Journal:  Biotechnol Bioeng       Date:  2015-07-14       Impact factor: 4.530

4.  Application of enhanced electronegative multimodal chromatography as the primary capture step for immunoglobulin G purification.

Authors:  Yanli Wang; Quan Chen; Mo Xian; Rui Nian; Fei Xu
Journal:  AMB Express       Date:  2018-06-01       Impact factor: 3.298

5.  Recombinant Thrombomodulin Suppresses Histone-Induced Neutrophil Extracellular Trap Formation.

Authors:  Binita Shrestha; Takashi Ito; Midori Kakuuchi; Takaaki Totoki; Tomoka Nagasato; Mika Yamamoto; Ikuro Maruyama
Journal:  Front Immunol       Date:  2019-10-29       Impact factor: 7.561

6.  Enhancing Protein A performance in mAb processing: A method to reduce and rapidly evaluate host cell DNA levels during primary clarification.

Authors:  Kenneth C Koehler; Zona Jokondo; Janani Narayan; Alexei M Voloshin; Angelines A Castro-Forero
Journal:  Biotechnol Prog       Date:  2019-08-13

7.  Multiple-Monitor HPLC Assays for Rapid Process Development, In-Process Monitoring, and Validation of AAV Production and Purification.

Authors:  Pete Gagnon; Blaz Goricar; Nina Mencin; Timotej Zvanut; Sebastijan Peljhan; Maja Leskovec; Ales Strancar
Journal:  Pharmaceutics       Date:  2021-01-17       Impact factor: 6.321

8.  Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate.

Authors:  Arik Makovitzki; Elad Lerer; Yaron Kafri; Yaakov Adar; Lilach Cherry; Edith Lupu; Arik Monash; Rona Levy; Ofir Israeli; Eyal Dor; Eyal Epstein; Lilach Levin; Einat Toister; Idan Hefetz; Ophir Hazan; Irit Simon; Arnon Tal; Meni Girshengorn; Hanan Tzadok; Osnat Rosen; Ziv Oren
Journal:  Vaccine       Date:  2021-10-22       Impact factor: 3.641

9.  Quantitative definition and monitoring of the host cell protein proteome using iTRAQ - a study of an industrial mAb producing CHO-S cell line.

Authors:  Lesley M Chiverton; Caroline Evans; Jagroop Pandhal; Andrew R Landels; Byron J Rees; Peter R Levison; Phillip C Wright; C Mark Smales
Journal:  Biotechnol J       Date:  2016-06-22       Impact factor: 4.677

10.  The effect of feed quality due to clarification strategy on the design and performance of protein A periodic counter-current chromatography.

Authors:  Hani El-Sabbahy; David Ward; Olotu Ogonah; Lynne Deakin; Gregory M Jellum; Daniel G Bracewell
Journal:  Biotechnol Prog       Date:  2018-10-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.